Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920504's Gross Margin % is ranked worse than 67.99% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs BJSE:920504: 40.12
Shanghai Boxun Medical Biological Instrument had a gross margin of 39.48% for the quarter that ended in Mar. 2026 => Competition eroding margins
Shanghai Boxun Medical Biological Instrument (BJSE:920504) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai Boxun Medical Biological Instrument had a gross margin of 39.48% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai Boxun Medical Biological Instrument Gross Margin % Related Terms
Shanghai Boxun Medical Biological Instrument Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument Gross Margin % Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument Gross Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Gross Margin % of 39.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is near median its historical median of 37.97. Over the past decade, Shanghai Boxun Medical Biological Instrument's Gross Margin % has ranged from 36.13 to 41.28. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #548 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 68%.
Is Shanghai Boxun Medical Biological Instrument's Gross Margin % too high?
Shanghai Boxun Medical Biological Instrument's current Gross Margin % of 39.48% is near median its 10-year median of 37.97. Over the past 10 years, this metric has ranged from a low of 36.13 to a high of 41.28. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Shanghai Boxun Medical Biological Instrument's value of 39.48% is 24.2% below this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #548 out of 806 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #548 out of 806 companies for Gross Margin %. This places Shanghai Boxun Medical Biological Instrument in the lower half of its industry. The industry median Gross Margin % is 52.12. Shanghai Boxun Medical Biological Instrument's value of 39.48% is 24.2% below this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own Gross Margin % has ranged from 36.13 to 41.28 over the past decade. While the company's 10-year median is 37.97 vs. the industry median of 52.12, Shanghai Boxun Medical Biological Instrument has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current Gross Margin % of 39.48% is 24.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current Gross Margin % is 39.48%, which is near median its own 10-year median of 37.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Gross Margin % is 39.48%, which is near median its 10-year median of 37.97 and 24.2% below the Medical Devices & Instruments industry median of 52.12. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Gross Margin % is 39.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
Gross Margin %: 39.48% (near median its 10-year median of 37.97)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 24.2% below the Medical Devices & Instruments median (#548 of 806)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
